These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36183548)

  • 21. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones.
    Toan DN; Thanh ND; Truong MX; Van DT
    Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Biological Evaluation and Docking Study of Mono- and Di-Sulfonamide Derivatives as Antioxidant Agents and Acetylcholinesterase Inhibitors.
    Güngör SA; Şahin İ; Güngör Ö; Tok TT; Köse M
    Chem Biodivers; 2022 Oct; 19(10):e202200325. PubMed ID: 35984664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel pyrrolopyrimidines and triazolopyrrolopyrimidines carrying a biologically active sulfonamide moieties as anticancer agents.
    Ghorab MM; Alsaisd MS; Nissan YM
    Acta Pol Pharm; 2015; 72(1):65-78. PubMed ID: 25850202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
    Hafez HN; El-Gazzar ABA
    Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.
    Sławiński J; Gdaniec M
    Eur J Med Chem; 2005 Apr; 40(4):377-89. PubMed ID: 15804537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound assisted one-pot synthesis of rosuvastatin based novel azaindole derivatives via coupling-cyclization strategy under Pd/Cu-catalysis: Their evaluation as potential cytotoxic agents.
    Kumar JS; Reddy GS; Medishetti R; Amirul Hossain K; Thirupataiah B; Edelli J; Dilip Bele S; Kristina Edwin R; Joseph A; Shenoy GG; Mallikarjuna Rao C; Pal M
    Bioorg Chem; 2022 Jul; 124():105857. PubMed ID: 35594765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
    Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactions.
    McCarroll AJ; Bradshaw TD; Westwell AD; Matthews CS; Stevens MF
    J Med Chem; 2007 Apr; 50(7):1707-10. PubMed ID: 17343370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (
    Szafrański K; Sławiński J; Tomorowicz Ł; Kawiak A
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents.
    Chen J; Liu T; Wu R; Lou J; Cao J; Dong X; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2010 Dec; 18(24):8478-84. PubMed ID: 21067933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and identification of heteroaromatic N-benzyl sulfonamides as potential anticancer agents.
    Hopkins MD; Abebe FA; Scott KA; Ozmer GL; Sheir AA; Schroeder LJ; Sheaff RJ; Lamar AA
    Org Biomol Chem; 2019 Sep; 17(36):8391-8402. PubMed ID: 31469373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
    Ullah S; El-Gamal MI; Zaib S; Anbar HS; Zaraei SO; Sbenati RM; Pelletier J; Sévigny J; Oh CH; Iqbal J
    Bioorg Chem; 2020 Jun; 99():103783. PubMed ID: 32224334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides.
    Saczewski J; Brzozowski Z; Saczewski F; Bednarski PJ; Liebeke M; Gdaniec M
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3663-7. PubMed ID: 16682194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein.
    Farman S; Javed A; Arshia ; Khan KM; Nasir A; Khan AU; Lodhi MA; Gul H; Khan F; Asad M; Parveen Z
    Anticancer Agents Med Chem; 2020; 20(14):1739-1751. PubMed ID: 32416700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
    Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAF
    Ali EMH; Abdel-Maksoud MS; Ammar UM; Mersal KI; Ho Yoo K; Jooryeong P; Oh CH
    Bioorg Chem; 2021 Jan; 106():104508. PubMed ID: 33280830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.